|Day's Range||48.85 - 49.18|
|52 Week Range||36.81 - 50.24|
|PE Ratio (TTM)||12.43|
|Dividend & Yield||1.58 (3.22%)|
|1y Target Est||N/A|
Sanofi's (SNY) Generics business contributes ~5% to the group's total revenues.
Revenues from Sanofi's Established Prescription Products rose 0.6% at constant exchange rates during 1Q17 and reported revenues of ~2.6 billion euros in 1Q17.
Sanofi's Diabetes and Cardiovascular franchise reported revenues of ~1.4 billion euros in 1Q17.